CRISTHIAM MAURICIO ROJAS HERNANDEZ to Anticoagulants
This is a "connection" page, showing publications CRISTHIAM MAURICIO ROJAS HERNANDEZ has written about Anticoagulants.
Connection Strength
1.891
-
Role of vena cava filters for the management of cancer-related venous thromboembolism: Systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018 Oct; 130:44-50.
Score: 0.431
-
The role of direct oral anticoagulants in cancer-related venous thromboembolism: a perspective beyond the guidelines. Support Care Cancer. 2018 Mar; 26(3):711-720.
Score: 0.412
-
Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis. J Thromb Thrombolysis. 2017 Feb; 43(2):233-240.
Score: 0.389
-
Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis. Thromb Res. 2017 Feb; 150:86-89.
Score: 0.386
-
External validation of the HIGH-2-LOW model: A predictive score for venous thromboembolism after allogeneic transplant. Am J Hematol. 2022 06 01; 97(6):740-748.
Score: 0.139
-
A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation: comment. J Thromb Haemost. 2016 10; 14(10):2080-2081.
Score: 0.094
-
Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism. Oncologist. 2023 Nov 02; 28(11):e1005-e1016.
Score: 0.039